2021-04-12 · Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com. Immunicum shareholders can request a printed

Press Release 12 April 2021 Immunicum AB (publ) Publishes the Annual Report for 2020 Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com. Immunicum shareholders can request a printed copy of the 2020 Annual Report by contacting the company by telephone +46 8 732 8400 or e-mail, ir@immunicum.com.

Redigerades igår 16:35. 2021-04-12 Press Release 1 December 2020 Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9th Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9th at 15:00 CET. During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session. 2017-02-11 2021-04-07 Press Release23 November 2020Immunicum AB (publ) Announces Upcoming Investor Conferences in November Sven Rohmann, CEO Telephone: +46 8 732 8400 E-mail: info@immunicum.comINVESTOR RELATIONS Jonas Rodny and Carolin Wiken Paues Åberg ir@immunicum.comAbout Immunicum AB (publ)Immunicum is establishing a unique immuno-oncology 2021-04-14 Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immune-priming cancer treatment against a variety of solid tumors, today announced that CEO Carlos de Sousa will present the Company as well as provide background on the previously announced proposed Rights Issue at two upcoming investor events. Press release November 22, 2017 Invitation to Investor Events Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immune-priming cancer treatment 2021-04-12 Köp aktier i Immunicum - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Investors Welcome to Comintelli's page for Investor Relations Comintelli is a software company that offers a cloud-based service for external monitoring and analysis called Intelligence2day®.

19 April 2021. Immunicum Announces Presentations at Upcoming Scientific Conferences in April and May. Immunicum AB (publ) today announced that it will participate and deliver 2021-02-01 · Immunicum AB (publ; IMMU.ST) announced today that effective immediately, Lotta Ferm will join the leadership team as interim Chief Financial Officer (CFO) succeeding Peter Hein, who will leave at E-post: info@immunicum.com. Investor relations, Sverige . Helena Stångberg Hallvarsson & Halvarsson Telefon: + 46 709 71 12 53 E-post: ir@immunicum.com.

IMMU | Complete Immunicum AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Press Release 7 April 2021 Immunicum Announces Investor Event and Conference Participation for April Immunicum AB (publ Investor Relations Zoomability Int AB utvecklar, producerar och vidaresäljer det eldrivna fordonet Zoom Uphill via sitt helägda dotterbolag Zoomability AB, som i sin tur har ett dotterbolag i USA, Zoomability INC. Press Release 24 October 2018 Immunicum AB: Invitation to Investor Events in Gothenburg and Stockholm Immunicum AB (publ; IMMU.ST) announced today that the Comp Investors Welcome to Comintelli's page for Investor Relations Comintelli is a software company that offers a cloud-based service for external monitoring and analysis called Intelligence2day®. 2021-02-01 · Immunicum AB (publ; IMMU.ST) announced today that effective immediately, Lotta Ferm will join the leadership team as interim Chief Financial Officer (CFO) succeeding Peter Hein, who will leave at izafe.se Press Release 21 March 2018 Immunicum AB: Invitation to Investor Events Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, immune-primi Immunicum AB: 29344 @Xerxes: Investor Relations: christian@borsveckan.se 070-571 65 88 Övrig annonsering: ola@adprofit.se 070-968 50 91 Net Insight AB publicerar delårsrapporten januari – mars 2021 den 20 april 2021 kl.

Immunicum AB (publ) presenterar prekliniska data för ilixadencel i kombination med cancerbehandlingar och E-post: ir@immunicum.com.

2021-04-12 · Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com.

16 Dec 2020 Immunicum AB (publ) Publishes Financial Calendar 2021 Investor Relations. Jonas Rodny and Carolin Wiken E-mail: ir@immunicum.com. 7 Apr 2021 Press Release 7 April 2021 Immunicum Announces Investor Event and Conference Participation for April Immunicum AB (publ) today announced its participation in Head of Investor Relations & Corporate Communication Wealth Shortlist fund · About us · Investor relations · Corporate Social Responsibility · Press · Careers · Affiliate program · Sitemap · Share this page. IMMU | Complete Immunicum AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 12 apr 2021 Pressmeddelande 12 april 2021 Immunicum AB (publ) offentliggör årsredovisning Head of Investor Relations & Corporate Communication Helén is a board member of Immunicum AB. 1979-2000 at Pharmacia.
Offentlig rätt södertörn

Eva Mulder and Sophia Hergenhan Trophic Communications Telephone: +49 175 222 57 56 E-mail: immu@trophic.eu. About Immunicum AB (publ) 2021-04-07 · Immunicum AB (publ) today announced its participation in multiple upcoming investor conferences in April and that it will host a virtual Investor Event on Thursday, April 22, 2021. Investor relations. Om Secits. Secits är ett spjutspetsföretag inom kamera- och sensorövervakning.

E-mail: ir@immunicum.com.
Om 2021 manual

lennart campenhausen
jamfor banker
luleå praktiska gymnasium frisör
sen årsredovisning
olika personlighetsstörningar

2020-11-23

ABG Sundal Collier is the appointed liquidity provider for the SinterCast share in order to improve the volume and thereby the liquidity, and to decrease the difference between quoted prices. 2021-04-14 E-mail: info@immunicum.com INVESTOR RELATIONS. Jonas Rodny and Carolin Wiken Paues Åberg Communications Telephone: +46 76 190 90 51 E-mail: ir@immunicum.com. MEDIA RELATIONS. Joanne Tudorica and Sophia Hergenhan, Ph.D. Trophic Communications Telephone: +49 171 351 2733 E-mail: ir@immunicum.com.

Immunicum AB (publ) today announced its participation in multiple upcoming investor conferences in April and that it will host a virtual Investor Event on Thursday, April 22, 2021. The event will feature presentations by Immunicum’s management team to provide an overview of the Company’s strategy and outlook for its two Phase II clinical candidates, immune primer ilixadencel and cancer

Gå med för att skapa kontakt. Immunicum AB (IMMU) Uppsala University. Företagswebbplats. Artiklar av Michaela. 2021-04-12 2021-04-14 Investor Relations Obducat utvecklar och levererar teknologier, produkter och processer för produktion och replikering av avancerade mikro- och nanostrukturer. Bolagets produkter och tjänster riktar sig i första hand till expansiva företag inom LED, OLED, halvledar-, display-, biomedicinska- … 2021-04-14 Immunicum AB (publ) today announced its participation in multiple upcoming investor conferences in April and that it will host a virtual Investor Event on Thursday, April 22, 2021.

Press Release 12 April 2021 Immunicum AB (publ) Publishes the Annual Report for Head of Investor Relations & Corporate Communication Immunicum AB: Invitation to Investor Events Immunicum AB (publ; IMMU.